Long-term use of AstraZeneca heart drug brings benefits, some risks

March 14, 2015 3:01 PM

3 0

Long-term use of AstraZeneca heart drug brings benefits, some risks

LONDON (Reuters) - Long-term use of AstraZeneca's drug Brilinta can cut the risk of death, another heart attack or stroke in patients with a history of past attacks by 16 percent, a keenly awaited clinical trial showed on Saturday.

The finding may boost sales of the blood-thinner, which AstraZeneca is relying on to drive growth, although doctors must balance its benefits against bleeding risks.

Also read: ECB sets Banco Popular's 2017 capital level at 7.875 percent

Read more

To category page

Loading...